Schedule 13G ownership disclosure
Benitec Biopharma Inc
Common Stock, par value $0.0001 · CUSIP: 08205P209
Event date: 2024-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Nantahala Capital Management, LLC
Shares: 1,038,371.00 · Class: 9.6539%
- Wilmot B. Harkey
Shares: 1,038,371.00 · Class: 9.6539%
- Daniel Mack
Shares: 1,038,371.00 · Class: 9.6539%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-119174
- Form type
- SCHEDULE 13G
- Filer
- Benitec Biopharma Inc.
- CIK
- CIK 1808898
- Filed
- Nov 14, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership